[Therapeutic aspects of prostaglandin research in gynecology].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T H Lippert.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
1. After intravenous administration of [(14)C]histamine in rabbits, the urinary excretion of [(14)C]histamine and [(14)C]histamine metabolites was examined over a period of 4 hr.2. It was found that [(14)C]histamine was excreted in the unchanged form only in small amounts (6-7%), while 54-71% was eliminated in the form of its metabolites.3. Under normal conditions, the percentage excretion of metabolites, but not of histamine, showed a dose dependence. With the higher [(14)C]histamine dose, a significantly smaller proportion of the dose given was excreted as metabolites than with the lower dose. The proportion of unchanged [(14)C]histamine excreted remained constant.4. Pre-treatment with histamine infusions, or with mepyramine maleate, caused an increase in the excretion of [(14)C]histamine metabolites while the excretion of [(14)C]histamine remained unchanged.5. Pre-treatment with a diuretic, a combination of mersalyl and theophylline, did not influence the excretion of [(14)C]histamine nor of its metabolites.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.